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Abstract 
Multiple studies have shown improvements in performance of livestock due to supplementation 
of polyunsaturated fatty acids (PUFA). Other studies have shown an effect of PUFA on fetal 
programming of offspring in livestock, though little work in this area has been done with 
ruminants. This research was conducted to evaluate the performance effect of ewes and their 
lambs when the ewes were supplemented with increasing concentrations of the PUFA 
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) as Ca salts during the last 50 d of 
gestation. The PUFAs were supplemented at concentrations of 0%, 1% and 2% of the diet fed to 
gestating ewes. Ewes (n=24 per treatment) started receiving the supplements 50 d prior (d -50) to 
expected lambing (d 1). Supplementation finished on lambing day and all ewes received the 
same diet after lambing.  Ewes were weighed, and body condition scored (BCS) at d -50, d -20, d 
15 and d 60 (weaning). On d 15 milk production and composition were evaluated after 3 hours of 
separation of the lamb from the ewe. Lambs were blood sampled (to measure plasma 
concentration of glucose and NEFA) and weighed on d 1, d 15, and d 60. Data were analyzed 
using a mixed model of SAS, using a linear and quadratic polynomial contrast for mean 
separation. There was a quadratic effect (P = 0.01) for ewe body weight (BW). Ewes 
supplemented with 1% PUFA were heavier than ewes supplemented with 0 or 2% (94.8 vs 91.0 
and 89.8 ± 1.06, respectively). There were no differences in BCS, milk production, fat or protein 
concentration, but there was a linear increase (linear P = 0.06) in lactose concentration.  There 
was no difference in lamb BW, or plasma glucose and NEFA concentrations (P > 0.1). However, 
there was a time by treatment interaction for average daily gain (ADG; P <0.05).  Lambs of ewes 
supplemented with PUFA at 1% showed a higher ADG (0.36 kg/d) than the 0% (0.31 kg/d) or 
2% (0.33 kg/d) supplementation groups. The ADG from d 15 to d 60 was similar for the three 
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treatments. A linear (P = 0.04) decrease in mRNA concentration of diacylglycerol 
acyltransferase 1, and quadratic changes (P < 0.06) in fatty acid binding protein 4, fatty acid 
transport protein 1, and peroxisome proliferator-activated receptor α were observed. This 
suggests that the supplementation of EPA and DHA during gestation affects ewe and lamb 
growth, and these effects may be dose dependent. The fact that the 1% EPA and DHA 
supplement showed a heavier BW for the ewes and the highest ADG for the lambs without 
affecting in the same manner MY or composition creates more questions to be answered 
regarding the biological effects of PUFA. Some of these performance changes could be 
attributed to changes in gene expression.  
Introduction  
Producers are always looking for ways to improve growth rates and overall performance 
of their livestock. Studies in livestock have shown that polyunsaturated fatty acids (PUFAs) are 
effective in improving biological performance (Lopes et al., 2009). However, PUFA absorption 
in ruminants is difficult because rumen microbes biohydrogenate these PUFAs before they are 
able to make it to the small intestine for absorption (Wachira et al., 2000). To avoid this problem 
Ca salts of PUFAs have been developed with different sources of fatty acids (Grummer, 1988). 
Despite the known function of the lipids as an energy source, PUFAs have been known to affect 
gene expression in lipolytic and lipogenic enzymes (Clark, 2001). Despite how much is known 
about the role of fatty acids in performance, there is little information on the effect of PUFAs as 
modifiers of fetal programing. Fetal programing refers to the fact that changes that occur in a 
dam during gestation may have an impact on the offspring (Du et al., 2009). Current research 
(Coleman et al., 2018a) has shown that feeding 0.39% of a Ca salt rich in DHA and EPA, during 
the last 50 days of gestation in ewes, modifies milk fatty acid composition even 30 days after 
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supplementation has ended, without affecting ewe or lamb performance until weaning. The lack 
of difference in performance could correspond to a lack of physiological effect of the PUFAs at 
this time, or that the amount used was not enough to produce changes.  
Based on the previous results, I hypothesize that EPA and DHA supplementation in late 
gestation has a dose dependent effect on ewes and their offspring performance and 
plasma metabolites, and on the ewe adipose tissue gene expression and performance. Therefore, 
the overall goal of this study was to determine if the use of different concentrations of EPA and 
DHA in the diet will have significant effects on the ewe performance (growth and milk 
production) and on their lamb after birth and into its adult life.  
Materials and Methods 
 This study was conducted at the Sheep Center of the Ohio Agricultural Research and 
Development Center, Wooster, Ohio (IACUC #2016A00000013). Seventy-two pregnant ewes 
were blocked by lambing dates and randomly assigned to the different treatments.  The ewes 
were also blocked based on body condition score (BCS) and placed in pens (experimental units) 
of three ewes. Ewes were divided into three groups (n=24, 8 pens per group) which received 
either 0%, 1%, or 2% of an enriched diet of EPA and DHA (StrataG113, Virtus Nutrition LLC, 
Corcoran, Ca). These doses were selected based on previous results (Coleman et al., 2018a) in 
which a lower dose did not change offspring performance at weaning but did change adipose 
tissue gene expression of the ewes. Ewes received this supplement along with a diet (Table 1) 
that met the NRC (2007) requirements for ewes in late gestation. They began receiving the fatty 
acid supplement 50 days prior to expected lambing day. At day -20, a subcutaneous adipose 
tissue sample was taken on one ewe per pen, as described by Coleman et al. (2018b). At lambing 
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the diet was discontinued and all ewes and lambs were moved to a common pen, where they 
received the same diet.  
 Within 12 hours following lambing, the lambs were weighed and bled (taken from the 
jugular vein). The lambs remained with their lactating mothers until approximately 60 days of 
age (weaning).  At 15 and 60 days of age the lambs were once again bled and weighed.  The 
weights were calculated to measure average daily gain (ADG). On day 15 milk production on the 
ewes was recorded as described in Coleman et al., (2018b). 
 Adipose tissue samples were used to measure mRNA concentration of genes involved in 
lipolysis and lipogenesis (Table 2). The method used for this analysis was the NanoString 
technology as described previously (Coleman et al., 2018b). 
 Blood samples were centrifuged the day of collection, and plasma was separated, 
aliquoted, and stored at – 80 degrees C until analysis. Plasma obtained from the lambs at d 0, 15, 
and 60 was used to measure glucose (Relling et al., 2010) and NEFA concentration (Johnson and 
Peters, 1993).    
 Ewe performance data, plasma glucose and NEFA concentrations were analyzed as a 
randomized complete block design with a repeated measurement procedure (SAS 9.4). The 
model considered the fixed effects of time, treatment and their interaction, and the random effect 
of ewes within the pens. For mRNA concentrations, a similar model was used without time and 
its interactions. As for the performance data of lambs, the model also included sex of the lambs 
and number of lambs at lambing (single, twin or triplets), as well as the actual time of sampling 
related to birth day as co-variables, which were removed from the model if they were not 
significant (P > 0.1). Linear and quadratic polynomial contrasts were used for mean separation.  
Results and Discussion 
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Dam performance 
 Ewe performance data in terms of body weight (BW) had a quadratic treatment effect (P 
< 0.01; Table 3). However, the effect was not as expected. Ewes supplemented with a 1% dry 
matter concentration of EPA and DHA had an average body weight of 89.8 kg. The ewes fed the 
2% supplement weighed 91.0 kg and 0% weighed 94.8 kg. Not only did BW decrease with 
increasing concentration, but the 1% supplement may have had more of an effect than the 2% 
concentration on the overall ewe BW. This may be explained by the adipose tissue gene 
expression data. As for BCS, no time by treatment effect was identified based on 
supplementation (P > 0.1; Table 3).  
 
Subcutaneous adipose tissue 
The genes used in the current study are involved in lipogenesis (Lipoprotein lipase, LPL; 
fatty acid synthase, FAS; diacylglycerol acyltransferases, DGAT 1 and 2), lipolysis (hormone 
sensitive lipase, HSL; adipose triglyceride lipase, ATGL) or fatty acids transport and signaling 
(fatty acid binding protein 4, FABP4; fatty acid transport protein 1, FATP1; and peroxisome 
proliferator-activated receptors α, β/ δ and γ). Subcutaneous adipose tissue gene expression 
exhibited linear and quadratic treatment effects (P < 0.1; Table 4). The mRNA concentration for 
DAGT1 had a linear decrease with the supplementation of EPA and DHA concentrations of 0%, 
1%, and 2%. This shows that the expression of the gene was down-regulated as the concentration 
increased, with the exception of 1% and 2% matching the results found for ewe body weight. As 
DAGT1 mRNA concentrations decreased, most likely so did translation of the enzyme DAGT1, 
meaning less formation of triglycerides (Lui et al., 2011). This may suggest that the ewe does not 
need to synthesis tryglicerides in the adipose tissue. This also suggests that 2% of an enriched 
 8 
source of EPA and DHA may be too high of a dosage. There was no effect on the mRNA 
concentration of LPL, FAS, DAGT2, HSL or ATGL. The concentration of mRNA for FATP1 
had quadratic treatment effects (P = 0.06; Table 4), where ewes supplemented with 0% (80.2) or 
2% (55.6) had a greater concentration than the ewes that received 1% (44.0). The pattern of 
mRNA concentration for FATP1 is similar to what was shown for DAGT1, which could imply 
that the transport of the fatty acid might be decreased, which downregulated the gene expression 
for the synthesis of new triglycerides. Past studies have shown that the expression of FATP1 
mRNA concentration changes in the placenta of bovine (Desantadina et al., 2018) due to 
physiological stage. Therefore, it is possible that this might be responsible for the mobilization of 
specific fatty acids to the fetus. However, the present study does not allow us to confirm that 
assumption. Also, the current data do not provide details of why the 1% supplemented fat would 
down-regulate the gene expression more than 2%. For mRNA of FABP4 and PPARα, there was 
a significant quadratic treatment effect (P < 0.05; Table 4). The receptor gene, FABP4, followed 
the increasing concentration of 0% (76089), 2% (126267.5), and 1% (171332.5). The gene 
FABP4 is involved in binding fatty acids to allow movement within the adipose cell (Coleman et 
al., 2018b). This would explain why the 1% value was higher than the 0% value. If the ewe is 
receiving more supplement and growing faster, she would be better utilizing fatty acids. This, 
again, does not explain why the 2% supplementation data would be lower than the 1% data. The 
only assumption that can be made as of now is that the 2% EPA and DHA supplement may have 
contained too much PUFA and resulted in fatty acids staying in storage. PPARα, which is 
involved in lipogenesis, again showed 1% as the lowest concentration amount of mRNA.  
 
Milk production and composition 
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Milk production, fat (%) and protein (%) were not affected by the different 
concentrations of EPA and DHA in the diet (P > 0.6), but there was a linear increase in lactose 
concentration (P =0.01; Table 5). The change in lactose concentration did not change the total 
energy produced per kilogram of milk or during the 3-hour period in which milking took place (P 
> 0.1; Table 5). The milk production data do not correlate with the lamb ADG data, in which 
lambs born to ewes supplemented with 1% EPA and DHA had greater ADG than the other 2 
treatments, but that difference was not due to an increase in milk production or energy by the 
ewe. Therefore, something else other than energy intake modified the growth of the lambs born 
to ewes supplemented with EPA and DHA. 
 
Lamb performance 
Significant differences in lamb final body weight were observed (P > 0.1) (Table 6).  
However, when data were analyzed as ADG, there was a time by treatment interaction (P < 
0.01). At day 15, lambs born to ewes supplemented with 1% PUFA had a higher ADG of 0.36 
kg/d.  The 0% supplementation had an ADG of 0.31 kg/d and the 2% group had an ADG of 0.33 
kg/d.  While there was a significant effect of supplementation on ADG from birth to 15 days of 
age, this again does not correspond with the hypothesis.  It was hypothesized that, as 
concentration increased, so would ADG.  However, 1% showed a higher ADG than the 2% 
supplementation. Average daily gain from day 15 to 60 did not show any difference due to 
supplementation. As described previously, the difference in ADG at day 15 was not associated 
with changes in milk yield or milk energy produced from the ewes. 
As of now there is no information or data to explain why the 1% concentrated 
supplement of EPA and DHA is more significant than that of the 2% concentration. As discussed 
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with the ewe data, this result may suggest that the supplementation of 2% overloaded the 
capability of the animal. Further research should focus on the first 15 days postpartum.  Also, 
more investigations should be done to examine why a smaller concentration of EPA and DHA in 
the diet would have a greater effect on lamb performance. The goal should be to find the 
optimum concentration to improve rate of gain. It is worth mentioning that these lambs had a 
different outcome of performance after weaning (Nickles et al., 2018). There was a linear 
increase in BW (P < 0.01) and a quadratic response for ADG (P < 0.08). Lambs born from 0 and 
1 % PUFA had similar ADG, whereas lambs born to ewes supplemented with 2 % PUFA had a 
10 % increase in ADG compared with lambs born to ewes supplemented with 0 and 1 % PUFA 
(Nickles et al., 2018). 
Glucose and NEFA concentrations also did not show any significant differences 
corresponding with the EPA and DHA supplementation of 0%, 1% and 2% (P > 0.1) (Table 6).  
These results are also dependent on many factors.  However, in this scenario we must assume 
that this is because the supplementation did not have an effect on plasma metabolites.  
In conclusion, ewe supplementation in late gestation with different doses of EPA and 
DHA had an impact on ewe and lamb performance in a nonlinear fashion. It decreases ewe BW 
at an inclusion rate of 1% of the enriched source of PUFA, but not at a rate of 2%. The change in 
performance is not associated with changes in adipose tissue gene expression despite the fact that 
DAGT1, FABP-4, FATP1 and PPAR α are changed. However, there was a time by dose fed 
treatment effect on lamb ADG from birth to weaning. This effect was temporary, and the 
weaning BW was similar for all treatment groups.  
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Tables 
 
Table 1: Diet composition (% DM basis) of diets containing 0, 1 or 2 % of supplemented 
enriched sources of EPA and DHA, fed to pregnant ewes at 2 kg/d during the last 50 d of 
gestation 
Ingredients 
Diet composition (% of DM bases) 
0% 1% 2% 
Corn Silage 30.54 30.54 30.54 
Alfalfa haylage 17.96 17.96 17.96 
Ground corn 10.10 8.89 7.97 
Soy hulls 30.65 30.88 30.81 
DDGS1 0.44 0.48 0.48 
limestone 10.10 10.07 10.04 
Mineral supplement2 0.20 0.18 0.18 
Ca salt supplement3  1.01 2.03 
1DDGS= Distiller’s dried grains with solubles. 
2Vitaferm Concept-Aid Sheep (BioZyme, St. Joeseph, MO). Contains 15.5% Ca, 5% P, 
16%  NaCl, 4% Mg, 2% K,  10 ppm Co, 70 ppm I, 2850 ppm Mn, 16.4 ppm Se, 2500 ppm Zn, 
130000 IU/kg vitamin A, 7500 IU/kg vitamin D3, 550 IU/kg vitamin E. 
3Strata G113 Virturs Nutrition 
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Table 2. Gene names and GenBank accession numbers 
Gene Name1 Accession Number 
LPL  NM_001009394.1 
ATGL  NM_001308576.1 
HSL NM_001128154.1 
DGAT1 NM_001110164.1 
DGAT2 XM_012096078.2 
FABP4 NM_001114667.1 
FAS XM_015098375.1 
FATP1 XM_015095580.1 
PPAR alpha XM_012175774.2 
PPAR beta/delta XM_004018768.3 
PPAR gamma NM_001100921.1 
Beta-actin NM_001009784.1 
Beta-2 microglobulin NM_001009284.2 
Ciclophilin A NM_001308578.1 
GAPDH NM_001190390.1 
PGK1 NM_001142516.1 
1 LPL = lipoprotein lipase; ATGL = adipose triglyceride lipase; HSL = hormone sensitive lipase; 
DGAT1 = diacylglycerol acyltransferase 1; DGAT2 = diacylglycerol acyltransferase 2; SCD = 
stearoyl-CoA desaturase; ELOVL2 = elongation of very long chain fatty acid 2; ELVL4 = 
elongation of very long chain fatty acid 4; ELOVL5 = elongation of very long chain fatty acid 5; 
FABP4 = fatty acid binding protein 4; FAS = fatty acid synthase; FATP1 = fatty acid transport 
protein 1; GIP = glucose-dependent insulinotropic polypeptide; RXR = retinoid X receptor; Cox-
2 = cyclooxygenase 2; 5-lox = 5-lipoxygenase; GAPDH = glyceraldehyde 3-phosphate 
dehydrogenase; PGK1 = phosphoglycerate kinase 
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Table 3: Body weight (BW) and body condition score (BCS) of ewes supplemented with 0, 1, or 
2 % EPA and DHA enriched diet during the last 50 days of gestation  
Item Treatment1 SEM P value 
0 1 2 Linear Quadratic 
BW, kg 94.8 89.8 91.0 1.06 0.25 < 0.01 
BCS 3.2 3.3 3.3 0.14 0.77 0.70 
 
1 Treatments on ewes supplemented with 0, 1, or 2 % EPA and DHA enriched diet during the last 
50 days of gestation; Body Condition Score measured on a scale of 1-5 
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Table 4: Concentration of mRNA from the subcutaneous adipose tissue obtained from late 
gestation ewes after 30 days of supplementation with 0, 1, or 2 % EPA and DHA enriched diets 
 
Item1 Trteatments2 SEM Treatment 
0 1 2 Linear Quadratic 
LPL 3495 5406 2831 1428 0.75 0.23 
FAS 8325 12347 14159 4220 0.26 0.80 
DAGT1 1162 610 695 176 0.04 0.08 
DAGT2 2705 7177 6172 2069 0.20 0.23 
HSL 5041 4643 3831 731 0.13 0.76 
ATGL 1502 1446 1211 217 0.24 0.67 
FABP4 76089 171332 126267 16074 0.62 0.05 
FATP1 80.2 44.0 55.6 12.6 0.09 0.06 
PPAR α 171 149 194 16 0.16 0.02 
PPAR β/δ 116 93 94 15 0.24 0.44 
PPAR γ 2107 2284 2126 238 0.95 0.55 
1 Gene expression is a relative value estimated using the mean of beta-actin, beta-2 
microglobulin, ciclophilin A, GAPDH and PGK1. LPL = lipoprotein lipase; FAS = fatty acid 
synthase; DGAT1 = diacylglycerol acyltransferase 1; DGAT2 = diacylglycerol acyltransferase 2; 
HSL = hormone sensitive lipase; ATGL = adipose triglyceride lipase; FABP4 = fatty acid 
binding protein 4; FATP1 = fatty acid transport protein 1; PPAR = peroxisome proliferator-
activated receptors. 
2 Treatments on ewes supplemented with 0, 1, or 2 % EPA and DHA enriched diet 
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Table 5. Milk production and milk composition on d 15 post lambing of ewes supplemented 
with 0, 1 or 2 % of Ca salts containing EPA and DHA during the last 50 days of gestation 
 
Item Treatment1 SEM P value 
0 1 2 Linear Quadratic 
Milk yield, mL 3 hrs 294.9 299.1 307.8 24.93 0.75 0.94 
Fat, % 8.1 7.8 7.8 0.38 0.66 0.74 
Protein, % 4.1 3.9 4.1 0.10 0.88 0.20 
Lactose, % 4.87 5.02 5.05 0.047 0.01 0.27 
Total solids, % 5.776 5.96 6.00 0.059 0.02 0.29 
MUN, % 14.75 13.75 13.32 1.341 0.51 0.87 
Milk Energy, Mcal/kg 4.862 4.756 4.803 0.151 0.79 0.66 
Milk energy, Mcal in 3 hrs 0.343 0.340 0.353 0.035 0.852 0.86 
 
1 Treatments on ewes supplemented with 0, 1, or 2 % EPA and DHA enriched diet during the last 
50 days of gestation 
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Table 6: Body weight (BW), average daily gain (ADG), and plasma glucose and NEFA 
concentration of lambs born to ewes that received 0, 1, or 2 % EPA and DHA enriched diet 
during the last 50 days of gestation 
 
Items Treatment1 SEM P value 
0 1 2 Time Time x 
treatment 
BW, kg 14.6 14.7 14.6 0.49 0.95 0.88 
ADG, d15, kg/d 0.31 0.36 0.33 
0.109 0.10 <0.01 
ADG, d30, kg/d 0.25 0.25 0.25 
Glucose 98.55 98.41 102.44 3.00 0.56 0.17 
NEFA 581.0 514.4 566.0 52.78 0.63 0.86 
 
1 Treatments on ewes supplemented with 0, 1, or 2 % EPA and DHA enriched diet during the last 
50 days of gestation; Average Daily Gain found from day 0-15, and day 0-30 
 
 
 
 
